Display options
Cite
Gumulec J, Raudenska M, Hlavna M, et al. Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol. Exp Ther Med. 2012;5(2):479-484doi: 10.3892/etm.2012.822.
Gumulec, J., Raudenska, M., Hlavna, M., Stracina, T., Sztalmachova, M., Tanhauserova, V., Pacal, L., Ruttkay-Nedecky, B., Sochor, J., Zitka, O., Babula, P., Adam, V., Kizek, R., Novakova, M., & Masarik, M. (2013). Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol. Experimental and therapeutic medicine, 5(2), 479-484. https://doi.org/10.3892/etm.2012.822
Gumulec, Jaromir, et al. "Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol." Experimental and therapeutic medicine vol. 5,2 (2013): 479-484. doi: https://doi.org/10.3892/etm.2012.822
Gumulec J, Raudenska M, Hlavna M, Stracina T, Sztalmachova M, Tanhauserova V, Pacal L, Ruttkay-Nedecky B, Sochor J, Zitka O, Babula P, Adam V, Kizek R, Novakova M, Masarik M. Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol. Exp Ther Med. 2013 Feb;5(2):479-484. doi: 10.3892/etm.2012.822. Epub 2012 Nov 20. PMID: 23403848; PMCID: PMC3570091.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2013 Feb;5(2):479-484. doi: 10.3892/etm.2012.822. Epub 2012 Nov 20.

Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol.

Experimental and therapeutic medicine

Jaromir Gumulec, Martina Raudenska, Marian Hlavna, Tibor Stracina, Marketa Sztalmachova, Veronika Tanhauserova, Lukas Pacal, Branislav Ruttkay-Nedecky, Jiri Sochor, Ondrej Zitka, Petr Babula, Vojtech Adam, Rene Kizek, Marie Novakova, Michal Masarik

Affiliations

  1. Department of Pathological Physiology, Faculty of Medicine; Brno University of Technology, Brno, Czech Republic.

PMID: 23403848 PMCID: PMC3570091 DOI: 10.3892/etm.2012.822

Abstract

Guinea pigs (Cavia porcellus) were treated with haloperidol (HP), and free radical (FR) and ferric reducing antioxidant power (FRAP) assays were used to determine oxidative stress levels. Furthermore, the superoxide dismutase (SOD), glutathione reductase (GR) and glutathione-S-transferase (GST) activity levels were detected and glucose levels and the reduced and oxidized glutathione (GSH/GSSG) ratio were measured in HP-treated and untreated guinea pigs. The present study demonstrated that the administration of HP causes significant oxidative stress in guinea pigs (P=0.022). In animals treated with HP, the activity of GST was significantly increased compared with a placebo (P= 0.007). The elevation of SOD and GR activity levels and increase in the levels of glutathione (GSH) in HP-treated animals were not statistically significant. In the HP-untreated animals, a significant positive correlation was observed between oxidative stress detected by the FR method and GST (r=0.88, P=0.008) and SOD (r=0.86, P= 0.01) activity levels, respectively. A significant negative correlation between the levels of plasma glucose and oxidative stress detected by the FRAP method was observed (r=-0.78, P=0.04). Notably, no significant correlations were observed in the treated animals. In the HP-treated group, two subgroups of animals were identified according to their responses to oxidative stress. The group with higher levels of plasma HP had higher enzyme activity and reactive oxygen species production compared with the group with lower plasma levels of HP. The greatest difference in activity (U/μl) between the two groups of animals was for GR.

Keywords: glutathione reductase; glutathione-S-transferase; guinea pig; haloperidol; oxidative stress; superoxide dismutase

References

  1. Arch Gen Psychiatry. 1988 Jan;45(1):79-91 - PubMed
  2. Brain Res. 1996 Apr 22;717(1-2):193-5 - PubMed
  3. Ann Pharmacother. 1997 Jun;31(6):736-7 - PubMed
  4. Biochem J. 1996 May 1;315 ( Pt 3):727-32 - PubMed
  5. Psychopharmacology (Berl). 1996 Jun;125(3):214-9 - PubMed
  6. Arch Gen Psychiatry. 1991 Mar;48(3):239-46 - PubMed
  7. Leg Med (Tokyo). 2012 May;14(3):147-53 - PubMed
  8. Curr Med Chem. 1999 Apr;6(4):279-309 - PubMed
  9. Mol Med Rep. 2012 Mar;5(3):705-9 - PubMed
  10. Am J Psychiatry. 1985 Oct;142(10):1137-45 - PubMed
  11. Biol Psychiatry. 1994 Oct 1;36(7):489-91 - PubMed
  12. Cell Mol Neurobiol. 1997 Apr;17(2):227-33 - PubMed
  13. Biochem J. 1998 Feb 15;330 ( Pt 1):175-9 - PubMed
  14. Xenobiotica. 1993 May;23(5):495-508 - PubMed
  15. Int J Mol Med. 2008 Feb;21(2):223-32 - PubMed
  16. Ann Neurol. 1993 May;33(5):512-7 - PubMed
  17. Kidney Int. 2003 Jan;63(1):179-85 - PubMed
  18. Can J Appl Physiol. 1998 Feb;23(1):23-55 - PubMed
  19. Acta Pharmacol Toxicol (Copenh). 1985 Feb;56(2):94-8 - PubMed
  20. EMBO J. 1999 Mar 1;18(5):1321-34 - PubMed
  21. Biochem Pharmacol. 1963 Oct;12:1181-91 - PubMed
  22. Molecules. 2010 Nov 29;15(12):8618-40 - PubMed
  23. Brain Res. 1998 Mar 30;788(1-2):215-22 - PubMed
  24. Dev Pharmacol Ther. 1982;4(1-2):12-7 - PubMed
  25. J Pharmacol Exp Ther. 1993 Jun;265(3):1137-41 - PubMed
  26. Int Clin Psychopharmacol. 1993 Fall;8(3):151-3 - PubMed
  27. Arzneimittelforschung. 1968 Mar;18(3):282-7 - PubMed

Publication Types